Monopar Therapeutics Inc.MNPRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.9%
5Y CAGR+18.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+24.9%/yr
vs +16.0%/yr prior
5Y CAGR
+18.6%/yr
Recent acceleration
Acceleration
+8.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.74M | +81.8% |
| 2024 | $3.16M | -2.3% |
| 2023 | $3.23M | +9.7% |
| 2022 | $2.95M | +11.8% |
| 2021 | $2.63M | +7.8% |
| 2020 | $2.44M | +3.8% |
| 2019 | $2.36M | +44.7% |
| 2018 | $1.63M | +39.6% |
| 2017 | $1.17M | +27.8% |
| 2016 | $912474.00 | - |